]>
IRCT20220313054270N1 IRCT 2022-11-01 Sabzevar University of Medical Sciences The effect of Vitamin D and Vitamin E on the severity of postpartum pain The effect of Vitamin D and Vitamin E on the severity of postpartum pain 2022-10-11 anticipated 43 Complete https://irct.ir/trial/62820 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Based on the days of the week, the research units will be divided into two groups A (intervention group) (Saturdays, Mondays, Wednesdays) and group B (control groups) (Sundays, Tuesdays, Thursdays). 4 postpartum pain. Intervention 1: Intervention group: each person receives a packet containing 8 vitamin E with a dose of 100 mg and 8 vitamin D with a dose of 400 mg. and every 6 hours, they take one vitamin D and one vitamin E, and after every 6 hours, for 8 times. the pain level is measured by the McGill ruler. Intervention 2: Control group: It does not receive any interference. Routine hospital care. Yes - There is a plan to make this available What will be shared: After the publication of the article, confidential information such as patient and hospital details will be removed and other information will be provided to the researchers When: After the publication of the article To whom: Medical experts Conditions: Medical professionals can access the data for research purposes Where to obtain: Refer to the email of the responsible author. How to obtain: Official and academic email to the corresponding author Comments:
public Mina Ghalenovi
Nuclear Martyrs Ave, Sabzevar University of Medical Sciences
Sabzevar Iran (Islamic Republic of) 9613943491 +98 51 4422 6958 Minaghalenovi@yahoo.com Sabzevar University of Medical Sciences scientific Mina Ghalenovi
Nuclear Martyrs Ave, Sabzevar University of Medical Sciences
Sabzevar Iran (Islamic Republic of) 9613943491 +98 51 4422 6958 Minaghalenovi@yahoo.com Sabzevar University of Medical Sciences Iran (Islamic Republic of) The mother must be literate. The age of the mother should be between 18-35 years. Their delivery is natural and the first or second delivery. Pregnancy age is between 42-37 weeks. The mother is breastfeeding. The exit of the placenta and the curtains is done spontaneously. The mother has moderate to severe back pain. 18 years 35 years Female The mother has not suffered a grade 3 or 4 perineal rupture. Epidural or spinal anesthesia is not used. During or before delivery, the drug has not been used to relieve pain, or 4 hours or more have passed since its us The mother should not be addicted to drugs. The mother does not have known chronic diseases (hypertension, diabetes, heart disease, infectious disease, lung disease, asthma) The mother has no history of abdominal and pelvic surgery The mother should not have symptoms of vitamin D deficiency (including bone and muscle pain, headache, and constant fatigue The patient has no history of vitamin D3 deficiency. Z39.2 Encounter for routine postpartum follow-up Treatment - Drugs N/A Intervention group: each person receives a packet containing 8 vitamin E with a dose of 100 mg and 8 vitamin D with a dose of 400 mg. and every 6 hours, they take one vitamin D and one vitamin E, and after every 6 hours, for 8 times. the pain level is measured by the McGill ruler. Control group: It does not receive any interference. Routine hospital care Severity of postpartum pain. Timepoint: 2 hours after delivery and then every 6 hours up to eight times. Method of measurement: Through the McGill pain scale (to reach less than 4 after the intervention). The amount of painkillers used. Timepoint: 2 hours after delivery and then every 6 hours, the consumption of painkillers is checked. Method of measurement: patient file. The amount of pain. Timepoint: 2 hours after delivery and then every 6 hours up to 8 times. Method of measurement: Via McGill ruler. Sabzevar University of Medical Sciences Approved 2021-11-20 Ethics committee of Sabzevar University of Medical Sciences Nuclear Martyrs Ave, Sabzevar University of Medical Sciences Sabzevar Razavi Khorasan Iran (Islamic Republic of)